Villasante A - Search Results

1

Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model.

Villasante A, Corominas J, Alcon C, Garcia-Lizarribar A, Mora J, Lopez-Fanarraga M, Samitier J. Villasante A, et al. Cancers (Basel). 2024 Mar 5;16(5):1060. doi: 10.3390/cancers16051060. Cancers (Basel). 2024. PMID: 38473417 Free PMC article.

2

Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells.

Villasante A, Godier-Furnemont A, Hernandez-Barranco A, Coq JL, Boskovic J, Peinado H, Mora J, Samitier J, Vunjak-Novakovic G. Villasante A, et al. Transl Res. 2021 Nov;237:82-97. doi: 10.1016/j.trsl.2021.06.006. Epub 2021 Jul 2. Transl Res. 2021. PMID: 34217898 Free PMC article.

3

Engineering Biomimetic Nanoparticles through Extracellular Vesicle Coating in Cancer Tissue Models.

Quiñonero G, Gallo J, Carrasco A, Samitier J, Villasante A. Quiñonero G, et al. Among authors: villasante a. Nanomaterials (Basel). 2023 Dec 7;13(24):3097. doi: 10.3390/nano13243097. Nanomaterials (Basel). 2023. PMID: 38132993 Free PMC article.

4

Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties.

Tornín J, Villasante A, Solé-Martí X, Ginebra MP, Canal C. Tornín J, et al. Among authors: villasante a. Free Radic Biol Med. 2021 Feb 20;164:107-118. doi: 10.1016/j.freeradbiomed.2020.12.437. Epub 2021 Jan 2. Free Radic Biol Med. 2021. PMID: 33401009 Free PMC article.

5

Human Serum Enhances Biomimicry of Engineered Tissue Models of Bone and Cancer.

Villasante A, Robinson ST, Cohen AR, Lock R, Guo XE, Vunjak-Novakovic G. Villasante A, et al. Front Bioeng Biotechnol. 2021 Jul 13;9:658472. doi: 10.3389/fbioe.2021.658472. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34327193 Free PMC article.

6

Recent Advances in Biomimetic Nanocarrier-Based Photothermal Therapy for Cancer Treatment.

Gallo J, Villasante A. Gallo J, et al. Among authors: villasante a. Int J Mol Sci. 2023 Oct 23;24(20):15484. doi: 10.3390/ijms242015484. Int J Mol Sci. 2023. PMID: 37895165 Free PMC article. Review.

7

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.

Villasante A, Sakaguchi K, Kim J, Cheung NK, Nakayama M, Parsa H, Okano T, Shimizu T, Vunjak-Novakovic G. Villasante A, et al. Theranostics. 2017 Sep 21;7(17):4099-4117. doi: 10.7150/thno.20730. eCollection 2017. Theranostics. 2017. PMID: 29158813 Free PMC article.

8

Bioengineered tumors.

Villasante A, Vunjak-Novakovic G. Villasante A, et al. Bioengineered. 2015;6(2):73-6. doi: 10.1080/21655979.2015.1011039. Epub 2015 Jan 23. Bioengineered. 2015. PMID: 25616977 Free PMC article.

9

Tissue-Engineered Model of Human Osteolytic Bone Tumor.

Villasante A, Marturano-Kruik A, Robinson ST, Liu Z, Guo XE, Vunjak-Novakovic G. Villasante A, et al. Tissue Eng Part C Methods. 2017 Feb;23(2):98-107. doi: 10.1089/ten.TEC.2016.0371. Tissue Eng Part C Methods. 2017. PMID: 28068876 Free PMC article.

10

Tissue-engineered models of human tumors for cancer research.

Villasante A, Vunjak-Novakovic G. Villasante A, et al. Expert Opin Drug Discov. 2015 Mar;10(3):257-68. doi: 10.1517/17460441.2015.1009442. Epub 2015 Feb 7. Expert Opin Drug Discov. 2015. PMID: 25662589 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page